Holen Sie sich die Stockscreener-App
1.33
3.08%
0.03
Schlusskurs vom Vortag:
$1.30
Offen:
$1.27
24-Stunden-Volumen:
67,583
Relative Volume:
0.16
Marktkapitalisierung:
$41.99M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-69.00M
KGV:
-0.4784
EPS:
-2.78
Netto-Cashflow:
$-55.26M
1W Leistung:
-3.60%
1M Leistung:
-4.29%
6M Leistung:
-75.81%
1J Leistung:
-85.42%
1-Tages-Spanne:
$1.27
$1.34
1-Wochen-Bereich:
$1.27
$1.435
52-Wochen-Spanne:
$1.05
$10.16
Acrivon Therapeutics Inc Stock (ACRV) Company Profile
Firmenname
Acrivon Therapeutics Inc
Sektor
Branche
Telefon
617-207-8979
Adresse
480 ARSENAL WAY, SUITE 100, WATERTOWN
Vergleichen Sie ACRV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ACRV
Acrivon Therapeutics Inc
|
1.335 | 43.72M | 0 | -69.00M | -55.26M | -2.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.13 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
602.49 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.94 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
666.09 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
310.14 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Acrivon Therapeutics Inc Stock (ACRV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-05 | Fortgesetzt | Piper Sandler | Overweight |
| 2025-01-31 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-09-16 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2024-04-29 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2024-03-01 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-12-15 | Fortgesetzt | Jefferies | Buy |
| 2023-10-05 | Eingeleitet | Maxim Group | Buy |
| 2023-06-02 | Eingeleitet | Oppenheimer | Outperform |
| 2023-05-08 | Eingeleitet | BMO Capital Markets | Outperform |
| 2023-04-27 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2023-04-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-12-12 | Eingeleitet | Cowen | Outperform |
| 2022-12-12 | Eingeleitet | Jefferies | Buy |
| 2022-12-12 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Acrivon Therapeutics Inc Aktie (ACRV) Neueste Nachrichten
Is this a good reentry point in Acrivon Therapeutics Inc.Market Sentiment Report & Free Growth Oriented Trading Recommendations - Newser
Acrivon Therapeutics Inc. Recovery Likely Here’s What Data ShowsPortfolio Performance Report & High Win Rate Trade Tips - kangso.co.kr
Price Action Confirms Reversal in Acrivon Therapeutics Inc. TrendWeekly Stock Analysis & Consistent Income Trade Recommendations - classian.co.kr
ACR-368 OncoSignature assay gains FDA breakthrough status - MSN
Is Acrivon Therapeutics Inc. stock a good hedge against inflation2025 Market Outlook & Capital Efficient Trade Techniques - Newser
Using fundamentals and technicals on Acrivon Therapeutics Inc.July 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser
Acrivon Therapeutics Inc. stock chart pattern explained2025 Technical Patterns & Consistent Income Trade Recommendations - Newser
Real time breakdown of Acrivon Therapeutics Inc. stock performance2025 Investor Takeaways & Real-Time Sentiment Analysis - Newser
What indicators show strength in Acrivon Therapeutics Inc.July 2025 Drop Watch & Comprehensive Market Scan Insights - Newser
Acrivon Therapeutics Inc. stock prediction for this weekMarket Activity Recap & Weekly Sector Rotation Insights - Newser
Visual analytics tools that track Acrivon Therapeutics Inc. performanceJuly 2025 Selloffs & Precise Swing Trade Alerts - Newser
Smart tools for monitoring Acrivon Therapeutics Inc.’s price actionWeekly Stock Recap & Low Risk Entry Point Guides - Newser
Full technical analysis of Acrivon Therapeutics Inc. stockJuly 2025 Catalysts & Fast Exit Strategy with Risk Control - Newser
What does recent volatility data suggest for Acrivon Therapeutics Inc.Earnings Trend Report & Expert Approved Momentum Ideas - Newser
Why Acrivon Therapeutics Inc. is moving todayRecession Risk & Weekly High Potential Stock Alerts - Newser
How to recover losses in Acrivon Therapeutics Inc. stockEarnings Summary Report & Consistent Income Trade Recommendations - Newser
How institutional ownership impacts Acrivon Therapeutics Inc. stockQuarterly Market Review & Capital Efficiency Focused Strategies - Newser
Can volume confirm reversal in Acrivon Therapeutics Inc.July 2025 Patterns & Risk Controlled Swing Alerts - Newser
Understanding Acrivon Therapeutics Inc.’s price movementJuly 2025 Action & Technical Pattern Based Buy Signals - Newser
Published on: 2025-08-19 01:37:39 - Newser
Best data tools to analyze Acrivon Therapeutics Inc. stockWeekly Risk Report & Consistent Income Trade Ideas - Newser
Relative strength of Acrivon Therapeutics Inc. in sector analysisTrade Signal Summary & AI Forecasted Entry/Exit Points - Newser
Acrivon Therapeutics Inc. Company Revenue and Profit Trends: A Deep Dive2025 Price Action Summary & Fast Entry Momentum Alerts - Newser
Acrivon Therapeutics’ SWOT analysis: precision medicine stock faces pivotal trials - Investing.com
Research Analysts Set Expectations for ACRV Q3 Earnings - Defense World
Momentum divergence signals in Acrivon Therapeutics Inc. chartWeekly Trade Review & High Win Rate Trade Alerts - Newser
Is Acrivon Therapeutics Inc. stock entering bullish territoryWeekly Risk Report & Weekly Top Gainers Trade List - Newser
Is Acrivon Therapeutics Inc. forming a double bottomQuarterly Performance Summary & Low Risk Entry Point Tips - 선데이타임즈
Historical volatility pattern of Acrivon Therapeutics Inc. visualizedOil Prices & Free Technical Pattern Based Buy Signals - Newser
Is Acrivon Therapeutics Inc. a potential multi baggerDip Buying & Technical Pattern Recognition Alerts - thegnnews.com
Is Acrivon Therapeutics Inc. stock a smart retirement pick2025 Price Targets & Weekly Momentum Stock Picks - newsyoung.net
Acrivon Therapeutics, Inc.: Promising Clinical Developments and Strong Financial Position Justify Buy Rating - TipRanks
Detecting support and resistance levels for Acrivon Therapeutics Inc.Quarterly Investment Review & Low Drawdown Momentum Ideas - Newser
Real time alert setup for Acrivon Therapeutics Inc. performanceMarket Volume Summary & Technical Pattern Alert System - Newser
Why Acrivon Therapeutics Inc. stock attracts strong analyst attentionWatch List & Weekly Momentum Picks - Newser
Short interest data insights for Acrivon Therapeutics Inc.Fed Meeting & Real-Time Buy Signal Alerts - Newser
Finanzdaten der Acrivon Therapeutics Inc-Aktie (ACRV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Acrivon Therapeutics Inc-Aktie (ACRV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 10% Owner |
May 01 '25 |
Sale |
1.34 |
298,886 |
400,507 |
3,104,139 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 25 '25 |
Sale |
1.95 |
1,054,669 |
2,056,605 |
4,306,189 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 29 '25 |
Sale |
1.41 |
250,000 |
352,500 |
3,840,906 |
| PERCEPTIVE ADVISORS LLC | 10% Owner |
Apr 28 '25 |
Sale |
1.56 |
215,283 |
335,841 |
4,090,906 |
1.03%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):